SQLite Web: event

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000120.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000120.txt","company":"SOPHiA GENETICS SA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000120.txt","article_chars":2751,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_b1342e9573e10213","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000120.txt","content_type":"text/plain","enriched_at":"2026-04-09T17:45:21.684050+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000120.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000120.txt","source_event_id":"evt_01d34f4b38c9","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"0db3db51065f2806","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-08","2026-04-06","2026-04-07","2026-04-02","2026-04-03"],"entities":[{"asset_class":"equity","name":"SOPHiA GENETICS SA","relevance":"high","symbol":"SOPH","type":"issuer"},{"asset_class":"equity","name":"Abhimanyu Verma","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Elimara Brunetto","relevance":"low","symbol":"","type":"attorney_in_fact"}],"event_type":"listing","information_gaps":["No prior known state is provided in the signal, so the 'what changed vs prior' delta cannot be determined from the provided text alone.","The filing text excerpt does not include the full table/columns beyond the extracted values; exact mapping of each numeric field to SEC Form 4 columns is not fully verifiable from the snippet.","The excerpt contains two separate stated price ranges; it is unclear whether these correspond to different transaction subsets or are duplicated text."],"key_facts":["SEC filing: Form 4 for SOPHiA GENETICS SA (SEC Act: 1934 Act; SEC file number 001-40627).","Filing accession number: 0001840706-26-000120; filed as of date: 2026-04-08; conformed period of report: 2026-04-06.","Reporting person: Abhimanyu Verma, Chief Technology Officer.","Transaction dates shown: 2026-04-06 and 2026-04-07.","Security: Ordinary Shares.","Reported share amounts: 2,519 shares (2026-04-06) and 1,030 shares (2026-04-07).","Weighted-average prices reported in Column 4: $4.859 (for 2026-04-06) and $4.8701 (for 2026-04-07).","Footnote states the sales were to satisfy tax withholding obligations arising from vesting of restricted stock units on April 2 and 3, 2026.","Footnote states sales were effected pursuant to a pre-established Rule 10b5-1 trading plan and were not discretionary trades.","Footnote provides transaction price ranges: $4.71 to $4.95 (inclusive) and separately $4.74 to $4.96 (inclusive) (both stated in the provided text).","Footnote states the reporting person will provide full information on the number of shares sold at each separate price within the stated range upon written request."],"numeric_claims":[{"label":"Shares sold (2026-04-06)","value":"2519"},{"label":"Weighted-average price (2026-04-06)","value":"4.859"},{"label":"Shares sold (2026-04-07)","value":"1030"},{"label":"Weighted-average price (2026-04-07)","value":"4.8701"},{"label":"Price range stated (inclusive)","value":"$4.71 to $4.95"},{"label":"Alternate price range stated (inclusive)","value":"$4.74 to $4.96"}],"primary_claim":"Abhimanyu Verma sold SOPHiA GENETICS SA ordinary shares on 2026-04-06 and 2026-04-07 under a Rule 10b5-1 trading plan to satisfy tax withholding obligations from restricted stock unit vesting.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"SOPHiA GENETICS SA filed a Form 4 on 2026-04-08 reporting sales of ordinary shares by its Chief Technology Officer, Abhimanyu Verma, to satisfy tax withholding obligations tied to restricted stock unit vesting. The filing states the sales were executed under a pre-established Rule 10b5-1 trading plan and provides weighted-average prices and a transaction price range.","topics":["SEC Form 4","insider trading","Rule 10b5-1 plan","tax withholding","restricted stock units","ordinary shares"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 SOPHiA GENETICS SA \u00b7 Filed 20260408","ticker":"SOPH","tickers":["SOPH"],"title":"SOPH filed 4","url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000120.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — signals

Update row sig_1574b0eced49 in signals